About
Science
Pipeline
FX-909
FX-111
Presentations & Publications
News
Press Releases
IN THE NEWS
Join Us
Contact
Phase 0 Intratumoral Microdevice Study of FX-909 in Bladder Cancer Demonstrates On-Target Anti-Tumor Activity and Immune Modulation, Enhanced in Combination with Anti-PD-1
This links to an external website.
Continue
Customize
Reject All
Accept All
Powered by
✖
...
show more
►
Necessary Cookies
Standard
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional Cookies
Remark
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical Cookies
Remark
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement Cookies
Remark
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
►
Unclassified Cookies
Remark
Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
None
